Top Markets
Coin of the day
Novonesis (Novozymes) B Novonesis (Novozymes) B

Novonesis (Novozymes) B

NSISBC
Rank in Stocks #1197
Established in January 2024 through the amalgamation of Novozymes A/S and Chr.... Established in January 2024 through the amalgamation of Novozymes A/S and Chr. Hansen, Novonesis now stands as a prominent global leader in biosolutions. The firm's activities encompass the worldwide development and commercialization of industrial enzymes, diverse microorganisms, and vital biopharmaceutical ingredients. Distinctively, its Class B shares are listed independently and actively traded on various European exchanges.
Share Price
$72.44
Last synced: 2026-08-24
Market Cap
$20.13B
Change (1 day)
1.25%
Change (1 year)
17.60%
Country
DK
Trade Novonesis (Novozymes) B (NSISBC)
Dividend history for Novonesis (Novozymes) B (NSISBC)
Novonesis (Novozymes) B (stock symbol: NSISBC) made a total of 0 dividend payments.
The sum of all dividends (adjusted for stock splits) is : 0.00
Dividend yield (TTM) : 0
Dividend payments for Novonesis (Novozymes) B (NSISBC) from 2026 to 2026
Annual dividend payments
Year Dividend (stock split adjusted) Change
Not enough data for the provided dates.
List of all dividend payments
Year Dividend Change
Not enough data for the provided dates.
Dividend payments for similar companies or competitors
Company Number of dividend payments Country
134.00%
GB
0.00%
FR
162.00%
US
161.00%
US
171.00%
US